MediFab

Medical Devices & EquipmentSeries BSeoul, South Koreaimedifab.com

Latest round

Series B

Last raised

Oct 2025

Total raised

$20M

Investors

12

About MediFab

Based in Seoul, South Korea, and founded in 2016, MediFab develops, produces, and supplies prosthesis that replaces silicon and filler by using biomaterial for tissue repair and 3D printing technologies. In 2016, the company released Cellrix 3D's culture system, signed a contract with Seoul Boramae Hospital on cooperative research, and another contract with Seoul National University on university-industry technical service development. MediFab developed a 3D printing-based self-healing implant and made a casting trap for making 3D cell culture support in 2018. In 2019, the company received a patent from the United States for its method for manufacturing three-dimensional cell culture support's double crosslink and casting tray for manufacturing three-dimensional cell culture support. The company develops and manufactures Cellrix 3D, a culture system developed with new 3D cell culture technology that forms an implantable 3D culture deposited with cell, creates cell environment closest to in-vivo, and is suitable for researches such as stem cell, spheroid 3D culture, and cancer research.

Who invested in MediFab

12 investors across 2 rounds

See all investors in MediFab

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Oct 24, 2025

    Amount

    $17M

    Investors

    Locked

  2. Series A

    Oct 26, 2021

    Amount

    $3.4M

    Investors

    Locked

Questions about MediFab

Who invested in MediFab?

MediFab has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has MediFab raised?

MediFab has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did MediFab last raise money?

MediFab's most recent round on record is a Series B, in Oct 2025.

What does MediFab do?

Based in Seoul, South Korea, and founded in 2016, MediFab develops, produces, and supplies prosthesis that replaces silicon and filler by using biomaterial for tissue repair and 3D printing technologies.

Where is MediFab headquartered?

MediFab is headquartered in Seoul, South Korea.

Which VCs invest in companies like MediFab?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at MediFab's stage. Their profiles are linked below.

Raising like MediFab? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.